期刊文献+

去泛素化酶USP9X在etoposide促结肠癌细胞SW620凋亡中的作用研究 被引量:3

Effect of USP9X on apoptosis of colon cancer induced by etoposide
下载PDF
导出
摘要 目的:探讨USP9X在etoposide促结肠癌细胞SW620凋亡中的作用和可能的机制。方法:设计并合成USP9X的shRNA和对照shcontrol,采用半定量RT-PCR和Western blot检测干扰效率。结肠癌细胞SW620分别转染USP9X-shRNA和shcontrol后用etoposide处理,检测MCL1的蛋白水平变化并通过c-PARP的水平检测细胞的凋亡水平。结果:半定量RT-PCR和Western blot检测显示在SW620细胞中USP9X-shRNA能够显著降低USP9X的mRNA和蛋白的表达,抑制率达70%,该条shRNA可以作为有效干扰序列进行后续实验。20μg/mL etoposide处理24 h后,经c-PARP的水平检测发现感染USP9X-shRNA的SW620细胞比对照组细胞的凋亡率显著增加。结论:以RNA干扰技术沉默USP9X基因可增加结肠癌细胞SW620对etoposide的敏感性,显著增加etoposide诱导的结肠癌SW620细胞的凋亡,推测USP9X基因可能成为结肠癌基因治疗的一个新靶点。 Objctives: To investigate the effect of USP9X on apoptosis of colon cancer induced by etoposide and its potential mechanism. Methods: USP9X small hairpin RNA(shRNA) sequence and control shRNA sequence were designed and synthesized, and the interference effective of USP9X-shRNA was detected by semi-quantitative RT-PCR and Western btotting. After transfected with USP9X-shRNA and shcontrol, SW620 cells were treated with etoposide, the detection of c-PARP were used to analysis the apoptosis of the celt. Results: Semi-quantitative RT-PCR and Western blot showed that the mRNA and protein level of USP9X were downregulated in SW620 cells transfected with USP9X-shRNA, and the inhibition rate reach to 70%. The shRNA sequence worked well for the following experiments. After treated with 20μg/ml etoposide for 24h, SW620 cells transfected with USP9X-shRNA showed an obvious higher apoptosis rate than the control cells. Conclusion: RNA interference of USP9X can enhance the sensitive of human colon cancer cell line SW620 to etoposide. The apoptosis of SW620 that induced by etoposide was severely increased. USP9X gene may become the new target of gene therapy for colorectal cancer.
出处 《中国现代普通外科进展》 CAS 2014年第1期8-11,68,共5页 Chinese Journal of Current Advances in General Surgery
关键词 结肠肿瘤 USP9X ETOPOSIDE 凋亡 Colorectal neoplasmso USP9X Etoposideo Apoptosis
  • 相关文献

参考文献13

  • 1Hanahan D, Weinberg RA. The hallmarks of cancer [J]. Cell, 2000, 100(1 ):57-70.
  • 2Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation [J]. Cell, 2011,144(5):646-674.
  • 3Vucic D, Dixit VM, Wertz IE. Ubiquitylation in apoptosis: a post- translational modification at the edge of life and death [J]. Nat Rev Mol Cell Biol, 2011,12(7):439-452.
  • 4Schwickart M, Huang X, Lill JR, et al. Deubiquitinase USIOX stabilizes MCL1 and promotes tumour cell survival [J]. Nature, 2010,463(7277):103-107.
  • 5Luise C, Capra C, Donzelli M, et al. An atlas of altered expression of deubiquitinating enzymes in human cancer[J]. PLoS One, 2011,6 (1):e15891.
  • 6Dupont S, Mamidi A, Cordenonsi M, et al. FAM/USP9X, a deubiquitinating enzyme essential for TGFbeta signaling, controls Smad4 monoubiquitination[J]. Cell, 2009,136 ( 1 ): 123-135.
  • 7Zhang C, Cai TY, Zhu H, et al. Synergistic antitumor activity of gemcitabine and ABT-737 in vitro and in vivo through disrupting the interaction of USP9X and Mcl-1 [J]. Mol Cancer Ther, 2011,10 (7):1264-1275.
  • 8Gomez-Bougie P, Menoret E, Juin P, et al. Noxa controls Mule- dependent Mcl-1 ubiquitination through the regulation of the Mcl- 1/USP9X interaction [J]. Biochem Biophys Res Commun, 2011,413 (3) :460-464.
  • 9Nagai H, Noguchi T, Homma K, et al. Ubiquitin-like sequence in ASK1 plays critical roles in the recognition and stabilization by USP9X and oxidative stress-induced cell death [J]. Mol Cell, 2009, 36(5):805-818.
  • 10Grou CP, Francisco T, Rodrigues TA, et al. Identification of ubiquitin-specific protease 9X (USP9X) as a deubiquitinase acting on the ubiquitin-peroxin 5 (PEX5) thioester conjugate[J]. J Biol Chem, 2012,287(16):12815-12827.

二级参考文献33

  • 1邓凯贤,钟玲,姜梅贤,陈维贤,陈莹,何华.RNA干扰Survivin基因沉默对卵巢癌SKOV3及SKOV3/ADM细胞凋亡的影响[J].癌症,2005,24(8):945-950. 被引量:18
  • 2Lo YM. Fetal DNA in maternal plasma: biology and diagnosis applications [J]. Clin Chem, 2000, 46( 12): 1903-1906.
  • 3Tian XX, Pang JC, Zheng J, et al. Antisense epidermal growth factor receptor RNA transfection in human glioblastoma cells down- regulates telomerase activity and telomere length [ J]. Br J Cancer, 2002, 86(8) : 1328-1332.
  • 4Mozzelti S, Ferlini C, Concolino P, et al. Class Ⅲ beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients [ J ]. Clin Cancer Res, 2005, 11 ( 1 ) : 298 -305.
  • 5Gordinier ME, Kudelka AP, Kavanagh JJ, et al. Thiotepa in combination with cisplatin for primary, epithelial ovarian cancer: A phase I study [J]. Caneer, 2002, 12(6) : 710-714.
  • 6Ehabbakh GH, Awtrey CS. Current treatment for ovarian cancer[J]. Expert Opin Pharmacother, 2001,2(1 ): 109-124.
  • 7Scherr M, Eder M. Gene silencing by small regulatory RNAs in mammalian cells [J]. Cell Cycle, 2007, 6(4) : 444-449.
  • 8Li J, Feng Q, Kim JM, et al. Human ovarian cancer and cisplatin resistance : possible role of inhibitor of apoptosis proteins [ J]. Endocrinology, 2001, 142( 1 ) : 370-380.
  • 9Mnatovnai I, Cappellini A, Tazzari PL, et al. Caspase-dependent cleavage of 170-kDa P-glycoprotein duirng apoptosis of human T-lymphoblastoid CEM cells [ J ]. Cell Physiol, 2006, 207 (3) : 836-844.
  • 10Jorissen RN, Walker F, Pouliot N, et al. Epidermal growth factor receptor: mechanisms of activation and signalling [J]. Exp Cell Res, 2003, 284( 1 ) : 31-53.

共引文献24

同被引文献38

  • 1Peng J, Hu Q, Liu WP, et al. USP9X expression correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma. Diagn Pathol, 2013, 8(1): 177-185.
  • 2Crosas B. Deubiquitinating enzyme inhibitors and their potential in cancer therapy. Curt Cancer Drug Targets, 2014, 14(6): 506-516.
  • 3Fraile JIV[, Quesada V, Rodriguez D, et al. Deubiquitinases in cancer: new functions and therapeutic options. Oncogene, 2012, 31(19): 2373-2388.
  • 4Burger AM, Seth AK. The ubiquitin-mediated protein degradation pathway in cancer: therapeutic implications. Eur J Cancer, 2004, 40(15): 2217-2229.
  • 5Pal A, Young MA, Donato NJ. Emerging potential of therapeutic targeting of ubiquitin-specific proteases in the treatment of cancer. Cancer Res, 2014, 74(18): 4955-4966.
  • 6Reyes-Turcu FE, Wilkinson KD. Polyubiquitin binding and disassembly by deubiquitinating enzymes. Chem Rev, 2009, 109(4): 1495-1508.
  • 7Agrawal P, Chen YT, Schilling B, et al. Ubiquitin-specific peptidase 9, X-linked (USP9X) modulates activity of mammalian target of rapamycin (roTOR). J Biol Chem, 2012, 287(25): 21164-21175.
  • 8Populo H, Lopes IM, Soares P. The mTOR signalling pathway in human cancer. IntJMol Sci, 2012, 13(2): 1886-1918.
  • 9Schwickart M; Huang X, Lill JR, et al. Deubiquitinase usPgx stabilizes MCL1 and promotes turnout cell survival. Nature, 2010, 463(7277): 103-107.
  • 10Nagai H, Noguchi T, Homma K, et al. Ubiquitin-like sequence in ASK1 plays critical roles in the recognition and stabilization by USP9X and oxidative stress-induced cell death. Mol Cell, 2009, 36(5): 805-818.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部